Your browser doesn't support javascript.
loading
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Cable, Jennifer; Fauci, Anthony; Dowling, William E; Günther, Stephan; Bente, Dennis A; Yadav, Pragya Dhruv; Madoff, Lawrence C; Wang, Lin-Fa; Arora, Rahul K; Van Kerkhove, Maria; Chu, May C; Jaenisch, Thomas; Epstein, Jonathan H; Frost, Simon David William; Bausch, Daniel G; Hensley, Lisa E; Bergeron, Éric; Sitaras, Ioannis; Gunn, Michael D; Geisbert, Thomas W; Muñoz-Fontela, César; Krammer, Florian; de Wit, Emmie; Nordenfelt, Pontus; Saphire, Erica Ollmann; Gilbert, Sarah C; Corbett, Kizzmekia S; Branco, Luis M; Baize, Sylvain; van Doremalen, Neeltje; Krieger, Marco A; Clemens, Sue Ann Costa; Hesselink, Renske; Hartman, Dan.
Afiliação
  • Cable J; PhD Science Writer, New York, New York, USA.
  • Fauci A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
  • Günther S; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany.
  • Bente DA; University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, USA.
  • Yadav PD; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
  • Madoff LC; Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Wang LF; Department of Medicine, University of Massachusetts Chan School of Medicine, Worcester, Massachusetts, USA.
  • Arora RK; Duke-NUS Medical School, Singapore.
  • Van Kerkhove M; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Chu MC; Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Jaenisch T; World Health Organization, Geneva, Switzerland.
  • Epstein JH; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Frost SDW; Colorado School of Public Health, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Bausch DG; EcoHealth Alliance, New York, New York, USA.
  • Hensley LE; Microsoft Research, Redmond, Washington, USA.
  • Bergeron É; FIND, the global alliance for diagnostics, Geneva, Switzerland.
  • Sitaras I; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Gunn MD; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Geisbert TW; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Muñoz-Fontela C; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Krammer F; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • de Wit E; University of Manitoba, Winnipeg, Manitoba, Canada.
  • Nordenfelt P; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Saphire EO; Bernhard Nocht Institute for Tropical Medicine and German Center for Infection Research, Hamburg, Germany.
  • Gilbert SC; Department of Microbiology and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Corbett KS; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
  • Branco LM; Department of Clinical Sciences Lund, Infection Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
  • Baize S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • van Doremalen N; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Krieger MA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Clemens SAC; Zalgen Labs, Germantown, Maryland, USA.
  • Hesselink R; Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France.
  • Hartman D; Centre International de Recherche en Infectiologie (CIRI), Lyon, France.
Ann N Y Acad Sci ; 1518(1): 209-225, 2022 12.
Article em En | MEDLINE | ID: mdl-36183296
The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements-notably, in low-to-middle income countries-must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ebolavirus / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ebolavirus / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article